Thomas G. Roueche
Chief Executive Officer at Fesariustherapeutics, Inc.
Profile
Thomas G.
Roueche was the founder of Biosurface Engineering Technologies, Inc. founded in 2001, where he held the title of President, Chief Executive Officer & Director.
Currently, he is the President, Chief Executive Officer & Director at Fesariustherapeutics, Inc. since 2021.
Previously, he worked as the Director-New Market Development at InnerDyne, Inc. and as the Vice President-Sales & Marketing at Orthopedic Technology, Inc. Mr. Roueche completed his undergraduate degree from the University of Oklahoma in 1984.
Thomas G. Roueche active positions
| Companies | Position | Start |
|---|---|---|
Fesariustherapeutics, Inc.
 Fesariustherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fesariustherapeutics, Inc. is an American Brooklyn-based company that specializes in tissue repair biomaterial for reconstructive surgeons. The company's flagship product, Dermisphere™, is an intelligently patterned native-state hydrogel scaffold for dermal tissue regeneration. The scaffold is made of collagen microspheres incorporated in a self-assembling collagen hydrogel that provides an optimal environment for cells from surrounding healthy tissues to migrate into the hydrogel. The company was founded by Jason Spector, a renowned plastic surgeon, and has been led by CEO Thomas G. Roueche since 2021. | Chief Executive Officer | 2021-05-31 |
Former positions of Thomas G. Roueche
| Companies | Position | End |
|---|---|---|
InnerDyne, Inc.
 InnerDyne, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, InnerDyne, Inc. is a company that develops and manufactures minimally invasive surgical access products. The company is based in Sunnyvale, CA. InnerDyne was acquired by Tyco International Ltd. on December 01, 2000 for $173.80 million. | Corporate Officer/Principal | - |
Biosurface Engineering Technologies, Inc.
 Biosurface Engineering Technologies, Inc. Medical SpecialtiesHealth Technology Biosurface Engineering Technologies, Inc. was a holding company, which engaged in the development of proprietary therapeutic peptides as medical devices to improve bone and soft tissue repair. It offered amplex and soft tissue augmentation services. The company was founded by Thomas G. Roueche, Paul O. Zamora, William G. Mavity, and Linda M. Finn in 2001 and was headquartered in Rockville, MD. | Founder | - |
| Orthopedic Technology, Inc. | Sales & Marketing | - |
Training of Thomas G. Roueche
| University of Oklahoma | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
InnerDyne, Inc.
InnerDyne, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, InnerDyne, Inc. is a company that develops and manufactures minimally invasive surgical access products. The company is based in Sunnyvale, CA. InnerDyne was acquired by Tyco International Ltd. on December 01, 2000 for $173.80 million. | Health Technology |
Biosurface Engineering Technologies, Inc.
Biosurface Engineering Technologies, Inc. Medical SpecialtiesHealth Technology Biosurface Engineering Technologies, Inc. was a holding company, which engaged in the development of proprietary therapeutic peptides as medical devices to improve bone and soft tissue repair. It offered amplex and soft tissue augmentation services. The company was founded by Thomas G. Roueche, Paul O. Zamora, William G. Mavity, and Linda M. Finn in 2001 and was headquartered in Rockville, MD. | Health Technology |
| Orthopedic Technology, Inc. | Health Technology |
Fesariustherapeutics, Inc.
Fesariustherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fesariustherapeutics, Inc. is an American Brooklyn-based company that specializes in tissue repair biomaterial for reconstructive surgeons. The company's flagship product, Dermisphere™, is an intelligently patterned native-state hydrogel scaffold for dermal tissue regeneration. The scaffold is made of collagen microspheres incorporated in a self-assembling collagen hydrogel that provides an optimal environment for cells from surrounding healthy tissues to migrate into the hydrogel. The company was founded by Jason Spector, a renowned plastic surgeon, and has been led by CEO Thomas G. Roueche since 2021. | Health Technology |
- Stock Market
- Insiders
- Thomas G. Roueche
